Indeed, SpI2-6/IGF2R tumor suppressor functions have been widely demonstrated to be linked to its ability to sequestrate and degrade IGF-II through direct cell internalization [10,54], while this does not apply to IGF-I, which displays negligible binding to SpI2-6/IGF2R at physiological concentrations [55,56]. This evidence concerns the gene IGF2 and neoplasm.